Cargando…

拉曼光谱检测技术在早期肺癌诊断方面的研究进展

Lung cancer (LC) is the most common cancer and the leading cause of cancer-related death worldwide. The 5-year survival rate for LC remains low at 18% and is 5% for patients with metastatic disease, while the 5-year overall survival rate of patients with stage Ⅰ NSCLC can reach 77.9%, hence early di...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058664/
https://www.ncbi.nlm.nih.gov/pubmed/30037378
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.10
_version_ 1783341741198278656
collection PubMed
description Lung cancer (LC) is the most common cancer and the leading cause of cancer-related death worldwide. The 5-year survival rate for LC remains low at 18% and is 5% for patients with metastatic disease, while the 5-year overall survival rate of patients with stage Ⅰ NSCLC can reach 77.9%, hence early diagnosis and treatment of LC is the key to improve the prognosis. As a non-invasive detection technique, Raman spectroscopy can realize the non-destructive detection of the differences in molecular level structure between cancerous tissues and normal tissues, which can be used for the early diagnosis of lung cancer. The aim of this review is to summarize the progress of Raman spectroscopycombined with different tissue or body fluid samplesin the diagnosis of early LC.
format Online
Article
Text
id pubmed-6058664
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60586642018-08-23 拉曼光谱检测技术在早期肺癌诊断方面的研究进展 Zhongguo Fei Ai Za Zhi 综述 Lung cancer (LC) is the most common cancer and the leading cause of cancer-related death worldwide. The 5-year survival rate for LC remains low at 18% and is 5% for patients with metastatic disease, while the 5-year overall survival rate of patients with stage Ⅰ NSCLC can reach 77.9%, hence early diagnosis and treatment of LC is the key to improve the prognosis. As a non-invasive detection technique, Raman spectroscopy can realize the non-destructive detection of the differences in molecular level structure between cancerous tissues and normal tissues, which can be used for the early diagnosis of lung cancer. The aim of this review is to summarize the progress of Raman spectroscopycombined with different tissue or body fluid samplesin the diagnosis of early LC. 中国肺癌杂志编辑部 2018-07-20 /pmc/articles/PMC6058664/ /pubmed/30037378 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.10 Text en 版权所有©《中国肺癌杂志》编辑部2018 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title_full 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title_fullStr 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title_full_unstemmed 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title_short 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
title_sort 拉曼光谱检测技术在早期肺癌诊断方面的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058664/
https://www.ncbi.nlm.nih.gov/pubmed/30037378
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.10
work_keys_str_mv AT lāmànguāngpǔjiǎncèjìshùzàizǎoqīfèiáizhěnduànfāngmiàndeyánjiūjìnzhǎn
AT lāmànguāngpǔjiǎncèjìshùzàizǎoqīfèiáizhěnduànfāngmiàndeyánjiūjìnzhǎn